This may be because the majority of participants in the GHABS cohort were in the early stage of AD with intact cognition, when some Aβ or tau PET images were indistinguishable for visual assessment, especially for the tau tracer AV1451. This evidence concerns the gene MAPT and Alzheimer disease.